highperformr logo

AMILI 's Overview

Total employees45
HeadquartersSingapore
Founded2019

Amili Pte. Ltd. is Southeast Asia's first precision gut microbiome company, headquartered in Singapore. Founded in 2019, Amili is dedicated to advancing the understanding of the human gut microbiome and its impact on health, particularly within diverse Asian populations. The company builds the region's largest multi-ethnic microbiome database, offers microbiome testing services (including direct-to-consumer kits like BIO & ME), conducts research, and develops data-driven interventions and personalized probiotics (like GENIE). Amili collaborates with academic institutions, healthcare providers, and industry partners to translate microbiome science into tangible health outcomes, focusing on diagnostics, predictive analytics, and therapeutic applications to address various health conditions.

Where is AMILI 's Headquarters?

HQ Function

Serves as the central hub for Amili's research and development, clinical diagnostics, data science operations, strategic planning, and business development activities.

Notable Features:

Strategically located within the National University Hospital (NUH) Medical Centre, facilitating close collaborations with leading medical researchers and clinicians. The facility is equipped with advanced laboratories for microbiome sequencing and analysis.

Work Culture:

A dynamic, science-driven, and innovative environment. The culture fosters collaboration, continuous learning, and a strong sense of purpose aimed at improving health outcomes across Asia. Employees are typically passionate about biotechnology and personalized medicine.

HQ Significance:

The Singapore headquarters leverages the nation's robust research infrastructure, access to diverse talent, strong government support for biotech, and a strategic position to serve the broader Southeast Asian market.

Values Reflected in HQ: The choice of location within a leading medical and research hub underscores Amili's commitment to scientific rigor, innovation, evidence-based solutions, and collaboration in advancing regional healthcare.

Location:

Amili Pte. Ltd. has a primary focus on Southeast Asia, with established offices in Singapore and Malaysia. The company also has a significant presence and partnerships in Thailand, Indonesia, and India, with ongoing efforts to expand into Greater China. Globally, Amili supports functions such as building the world's largest multi-ethnic Asian gut microbiome databank, providing clinical diagnostics and direct-to-consumer testing, fostering international research collaborations, and developing microbiome-based health products tailored for diverse Asian populations.

Street Address:

1 Medical Drive, #05-02, National University Hospital (NUH) Medical Centre

City:

Singapore

State/Province:

Singapore

Country:

Singapore

AMILI 's Global Presence

Kuala Lumpur, Malaysia

Address: Level 28, G Tower, 199 Jalan Tun Razak, 50400 Kuala Lumpur

To expand Amili's reach in the Malaysian market, cater to the local demand for personalized gut health solutions, and contribute to the company's regional microbiome data collection efforts.

Buying Intent Signals for AMILI

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of AMILI

As of April 2025, AMILI ' leadership includes:

Dr. Jeremy Lim - Co-founder & Chief Executive Officer
Dr. David Ong - Co-founder & Chief Medical Officer
Dr. Jonathan Lee - Co-founder & Chief Scientific Officer
Pooja Vig - Co-founder & Chief Operating Officer

Investors of AMILI

AMILI has been backed by several prominent investors over the years, including:

Vulcan Capital
East Ventures
Pruksa Group
TVM Capital Healthcare
SEEDS Capital (Enterprise Singapore)
SGInnovate
Capital Code
GK Goh Holdings

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

As of late 2023/early 2024, there have been no major publicly announced executive new hires or departures at Amili Pte. Ltd. The founding executive team continues to spearhead the company's growth and strategic initiatives.

Technology (Tech Stack) used by AMILI

Discover the tools AMILI uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

AMILI Email Formats and Examples

Amili Pte. Ltd. appears to use a straightforward email format based on employee first names. This is a common practice for many modern tech and biotech companies.

[first_name]@amili.asia

Format

jeremy@amili.asia

Example

85%

Success rate

News and media

MobiHealthNewsNovember 21, 2023

Amili launches DIY gut microbiome test kit for consumers in SEA

Singapore-based microbiome company Amili has rolled out a direct-to-consumer gut health test kit. Called BIO & ME, the home test kit is now available in Singapore and Malaysia with plans for expansion to Thailand and Indonesia....more

BioSpectrum AsiaFebruary 22, 2023

Amili partners with Osstem Pharma to launch probiotics line in South Korea

Amili, Southeast Asia's first precision gut microbiome company, has announced its strategic partnership with Osstem Pharma, a leading South Korean pharmaceutical company. This collaboration marks Amili’s entry into the South Korean market with its personalised probiotics line, GENIE....more

TechCrunchJune 7, 2022

Amili grabs $10.5M Series A for its gut microbiome platform and library

Singapore-based Amili, Southeast Asia’s first precision gut microbiome company, announced today it has raised a $10.5 million Series A. The round was led by Vulcan Capital, the multi-billion-dollar investment arm of the late Microsoft co-founder Paul G. Allen, with participation from Pruksa Group, TVM Capital Healthcare and others....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including AMILI , are just a search away.